Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 1,020.00p on 29-10-2025 at 19:05:07
Change 40.00p 4.08%
Buy 1,045.00p
Sell 1,015.00p
Last Trade: Sell 183.00 at 1,020.00p
Day's Volume: 50,371
Last Close: 1,020.00p
Open: 1,085.00p
ISIN: GB00BQVXM815
Day's Range 1,015.00p - 1,120.00p
52wk Range: 0.876p - 1,790.00p
Market Capitalisation: £54.68m
VWAP: 1,078.49353p
Shares in Issue: 5.36m

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 183 1,020.00p Uncrossing Trade
16:35:28 - 29-Oct-25
Unknown* 2 1,015.00p OTC Trade
16:22:55 - 29-Oct-25
Sell* 10 1,015.00p SI Trade
16:22:55 - 29-Oct-25
Buy* 47 1,045.00p SI Trade
16:22:55 - 29-Oct-25
Sell* 3 1,015.00p Automatic Execution
16:22:55 - 29-Oct-25
Sell* 147 1,024.00p Ordinary
16:21:09 - 29-Oct-25
Buy* 500 1,044.40p Ordinary
16:20:46 - 29-Oct-25
Buy* 500 1,043.20p Ordinary
16:06:55 - 29-Oct-25
Buy* 500 1,043.17p Ordinary
16:05:41 - 29-Oct-25
Buy* 22 1,047.90p Ordinary
15:51:31 - 29-Oct-25
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Oct 2025 (Wed) 1,085.00 1,120.00 1,015.00 1,020.00 50,371
28th Oct 2025 (Tue) 920.00 1,080.00 892.00 980.00 46,038
27th Oct 2025 (Mon) 850.00 880.00 752.00 872.00 40,980
24th Oct 2025 (Fri) 904.00 910.00 760.00 868.00 60,708
23rd Oct 2025 (Thu) 950.00 1,025.00 900.00 900.00 19,093
22nd Oct 2025 (Wed) 996.00 996.00 964.00 964.00 9,132
21st Oct 2025 (Tue) 1,000.00 1,030.00 976.00 996.00 14,052
20th Oct 2025 (Mon) 1,000.00 1,020.00 942.00 1,000.00 13,889
17th Oct 2025 (Fri) 970.00 1,010.00 970.00 968.00 11,683
16th Oct 2025 (Thu) 944.00 1,025.00 944.00 990.00 17,734
15th Oct 2025 (Wed) 972.00 1,000.00 948.00 973.00 39,586
14th Oct 2025 (Tue) 1,100.00 1,100.00 980.00 1,010.00 49,387
13th Oct 2025 (Mon) 1,140.00 1,185.00 1,100.00 1,100.00 24,424
10th Oct 2025 (Fri) 1,200.00 1,200.00 1,100.00 1,140.00 17,206
9th Oct 2025 (Thu) 1,225.00 1,225.00 1,150.00 1,177.50 24,802
8th Oct 2025 (Wed) 1,205.00 1,300.00 1,205.00 1,235.00 33,840
7th Oct 2025 (Tue) 1,195.00 1,330.00 1,195.00 1,290.00 31,161
6th Oct 2025 (Mon) 1,090.00 1,290.00 1,090.00 1,165.00 54,378
3rd Oct 2025 (Fri) 1,060.00 1,100.00 1,045.00 1,080.00 23,932
2nd Oct 2025 (Thu) 1,195.00 1,195.00 1,060.00 1,082.50 39,028
1st Oct 2025 (Wed) 1,120.00 1,210.00 1,120.00 1,160.00 34,983
30th Sep 2025 (Tue) 1,135.00 1,300.00 1,105.00 1,162.50 58,829
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
29th Oct 2025 7:00 am RNS Clinical Trial Update and Grant of Share Awards
6th Oct 2025 7:00 am RNS Clearance to Initiate Pediatric Enrolment
30th Sep 2025 7:00 am RNS Half-year Report
30th Sep 2025 7:00 am RNS Total Voting Rights
23rd Sep 2025 7:00 am RNS Hemogenyx Signs Letter of Intent
18th Sep 2025 1:16 pm RNS Holding(s) in Company
17th Sep 2025 7:00 am RNS Third Patient Safety
11th Sep 2025 7:00 am RNS-R Invitation to Participate at DCNY Summit
8th Sep 2025 7:00 am RNS Manufacturing Partnership with Made Scientific
5th Sep 2025 7:00 am RNS Exercise of Warrants and Issue of Equity
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Hemogenyx says exploring commercialisation of treatment for leukaemia

23rd Sep 2025 15:51

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it is has signed a letter of intent with Cellin Technologies OU, a Tallinn-based cell therapy company. Read More

Hemogenyx shares jump as third patient treated for leukaemia form

17th Sep 2025 11:54

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia. Read More

Hemogenyx inks manufacturing partnership deal with Made Scientific

8th Sep 2025 16:27

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has agreed a manufacturing partnership with US-based cell therapy contract development and manufacturing organisation Made Scientific. Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value9,756.14
Change59.40

Login to your account

Forgot Password?

Not Registered